Home›Companies›Biotech & Pharma›Marea Therapeutics

Marea Therapeutics, Inc.

Updated Oct 27, 2026·Latest SEC filing Jun 24, 2024·Suggest an edit

About Marea Therapeutics

Marea Therapeutics is a private company based in San Francisco, California, incorporated in 2021 in Delaware. It has reported $65,418,629 raised in one offering on Form D since June 2024. Its chief executive is Josh Lehrer.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jun 11, 2024Jun 24, 2024$65,418,629of $160.4M target10$6.5MEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Marea Therapeutics's Form D filed Jun 24, 2024.

MJ
Mark Joing
Executive officer
JT
Jeff Tong
Director
CG
Christine Garrett
Executive officer
JL
Josh Lehrer
Chief Executive Officer and President, director
EW
Ethan Weiss
Executive officer
AR
CM
Caitlin Murray
Executive officer
JC
Jung Choi
Director
MK
Maha Katabi
Director
Also a director at Quanta Therapeutics.
TL
Ted Love
Director

Sources

  1. SECMarea Therapeutics, Inc. filing history